Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605548 | PMC |
| http://dx.doi.org/10.3389/fphar.2013.00031 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reliability and validity of the Londrina activities of daily living protocol in individuals with systemic sclerosis.
Clin Rheumatol
January 2025
Faculty of Physical Therapy and Rehabilitation, Cardiopulmonary Department, Dokuz Eylül University, Izmir, Turkey.
Purpose: To investigate the validity and reliability of the Londrina ADL Protocol in patients with systemic sclerosis (SSc).
Methods: The study included 39 individuals with SSc and 30 healthy participants aged 18-70 years. Performance-related ADL assessment was performed with the Londrina ADL Protocol which was performed twice by the same rater and energy expenditure during the test with the Dynaport Move Monitor device.
Dementia Care Research and Psychosocial Factors.
Alzheimers Dement
December 2024
Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Background: The risk of cognitive decline in cancer survivors may be increased by platinum-based chemotherapy. Evidence indicates that physical exercise has a potential to reduce chemotherapy-related toxicity. The aim of this study was to assess effects of a 6-month aerobic-strength training on cognitive functions, metabolic flexibility, anthropometric parameters and physical fitness in testicular germ cell tumor (TGCT) survivors, treated with platinum-based chemotherapy.
View Article and Find Full Text PDFTrends in cutaneous melanoma mortality and incidence in European Union 15+ countries between 1990 and 2019.
J Eur Acad Dermatol Venereol
January 2025
St Andrews Centre for Burns and Plastic Surgery, Broomfield Hospital, Chelmsford, Essex, UK.
Background: Cutaneous melanoma (CM) is the leading cause of skin cancer mortality with associated high healthcare costs. Up-to-date reporting of epidemiological trends for CM is required to project future trends, assess the burden of disease and aid evaluation of new diagnostic, therapeutic and preventative strategies.
Objectives: To describe the trends in CM mortality, incidence, mortality-to-incidence indices (MIIs) and disability-adjusted life years (DALYs) over the last three decades.
Willingness to pay for exercise oncology services: a mixed methods study.
Support Care Cancer
January 2025
Department of Health Services Research, Peter MacCallum Cancer Centre, Victoria, Australia.
Purpose: To evaluate cancer patients' willingness to pay for exercise services and oncology health professionals' perception of patients' willingness to pay.
Methods: A mixed-methods design was used. Online questionnaires and semi-structured interviews were administered to people with any type of cancer and oncology health professionals delivering clinical care.
Validity of the Actigraph-GT9X accelerometer for measuring steps and energy expenditures in heart failure patients.
PLoS One
January 2025
Department of Kinesiology and Health Science, Virginia Commonwealth University, Richmond, VA, United States of America.
Introduction: The ActiGraph (AG) accelerometer is widely used to assess physical activity (PA) in heart failure (HF) patients. However, the validity of the AG in this population remains unexplored.
Objective: Therefore, this study examined the criterion validity of the AG-GT9X for measuring step counts (SC) and energy expenditure (EE) among HF patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!